PP  Vol.3 No.1 , January 2012
Antidepressant-Like Activity of Tetramethylpyrazine Measured by Chronic Experimental Method in Rat Model of Depression
Abstract: The aim of this study was to investigate the potential antidepressive-like effect of tetramethylpyrazine (TMP), one of available blood-activating and stasis-eliminating components from traditional Chinese medicines, in chronic mild stress (CMS)-induced rat model of depression. Male Sprague-Dawley (SD) strain rats were divided into six matched groups (n = 13 or 14 in each group) based on their sucrose consumption: control, CMS, CMS + fluoxetine (FLU), and CMS + TMP groups. The rats except control were housed separately in different rooms, and the rat model of depression was established by exposing to an unpredictable sequence of stressors for 28 days; the rats in CMS + FLU were exposed to CMS and received administration of FLU (2.0 mg/kg/d, ig) for 28 days; the rats in CMS + TMP groups were exposed to CMS and received administration of TMP (10, 20, 40 mg/kg/d, ig), respectively, for 28 days. The rats in control group were given ordinary daily care, and the rats in control and CMS groups received ig administration of normal saline instead of FLU or TMP. The body weight, food intake and fluid consumption were measured, and the behaviors were examined by open field test before and after CMS, and forced-swimming test was performed 1 day after last unpredictable stressor. Chronic administration of TMP partially reversed the effects of CMS on consumption of sucrose solution and locomotion and exploration behavior, and potently shortened the immobility time during forced-swimming test following CMS in rats. The results showed that long-term administration of TMP partially reversed the effects of CMS on the body weight gain, the consumption of sucrose solution, the squares crossin gand rearing in open field test, and the immobility time during forced-swimming test in rats. The present data provide evidences that TMP possesses obvious antidepressant-like activity in CMS-induced rat model of depression.
Cite this paper: L. Yu, X. Jiang, Y. Zhang, M. Liao, R. Ma and T. Yu, "Antidepressant-Like Activity of Tetramethylpyrazine Measured by Chronic Experimental Method in Rat Model of Depression," Pharmacology & Pharmacy, Vol. 3 No. 1, 2012, pp. 52-57. doi: 10.4236/pp.2012.31008.

[1]   L. Bach-Rojecky, Z. Kalodjera and I. Samarzija, “The Antidepressant Activity of Hypericum Perforatum L. Measured by Two Experimental Methods on Mice,” Acta Pharmaceutica, Vol. 54, No. 2, 2004, pp. 157-162.

[2]   X. Zhong, Q. Mao, Z. Huang and J. Wei, “Anti-Depressive Effect of Suyu Capsules in Mice,” Chinese Journal of Natural Medicines, Vol. 15, No. 15, 2006, pp. 1247-1249.

[3]   H. B. Zhong, Y. Pan and L. D. Kong, “Antidepressant Effect of Epimedium Brevicornum Extracts,” Chinese Traditional and Herbal Drugs, Vol. 36, No. 10, 2005, pp. 1506-1510.

[4]   Q. Mao, Z. Huang, S. Ip and C. Che, “Antidepressant-Like Effect of Ethanol Extract from Paeonia Lactiflora in Mice,” Phytotherapy Research, Vol. 22, No. 11, 2008, pp. 1496-1499.

[5]   G. Liu, “Chinese Herbal Medicine,” Hua Xia Publishing House, Beijing, 2001, pp. 227-228.

[6]   H. B. Li and F. Chen, “Preparative Isolation and Purification of Chuanxiongzine from the Medicinal Plant Ligusticum Chuanxiong by High-Speed Counter-Current Chromatography,” Journal of Chromatography A, Vol. 1047, No. 2, 2004, pp. 249-253.

[7]   M. Su, Y. Zhou and G. Yang, “Effects of tetramethylpyrazine on L-Type Calcium-Channel Current and the Intracellular Calcium Concentration in Primary Cultured Hippocampal Neuronal Cells,” Chinese Journal of Rehabilitation, Vol. 23, No. 1, 2008, pp. 17-19.

[8]   Y. B. Ji, “Pharmacological Action and Application of Blood-Activating and Stasis-Eliminating Available Composition of Traditional Chinese Medicine,” Heilongjiang Science and Technique Press, Harbin, 1999, pp. 118-121.

[9]   L. Yu, X. Jiang, M. Liao, R. Ma, T. Yu, “Antidepressant-Like Effect of Tetramethylpyrazine in Mice and Rats,” Neuroscience & Medicine, Vol. 2, No. 6, 2011, pp. 142- 148.

[10]   P. Willner, A. Towell, D. Sampson, S. Sophokleous and R. Muscat, “Reduction of Sucrose Preference by Chronic Unpredictable Mild Stress, and Its Restoration by a Tricyclic Antidepressant,” Psychopharmacology, Vol. 93, No. 3, 1987, pp. 358-364. doi:10.1007/BF00187257

[11]   J. L. Moreau, F. Jenck, J.R. Martin, P. Mortas and W. E. aefely, “Antidepressant Treatment Prevents Chronic Unpredictabl Mild Stress-Induced Anhedonia as Assessed by Ventral Tegmentum Self-Stimulation Behavior in Rats,” European Neuropsychopharmacology, Vol. 2, No. 1, 1992, pp. 43-49. doi:10.1016/0924-977X(92)90035-7

[12]   K. T. Hallam, J.E. Horgan, C. McGrath and T. R. Norman, “An Investigation of the Effect of Tacrine and Physostigmine on Spatial Working Memory Deficits in the Olfactory Bulbectomised Rat,” Behavioural Brain Research, Vol. 153, No. 2, 2004, pp. 481-486. doi:10.1016/j.bbr.2004.01.005

[13]   R. D. Porsolt, G. Anton, N. Blavet and M. Jalfre, “Behaviour Despair in Rats: A New Model Sensitive to Antidepressant Treatments,” European Journal of Pharmacology, Vol. 47, No. 4, 1978, pp. 379-391. doi:10.1016/0014-2999(78)90118-8

[14]   L. E. Schechter, R. H. Ring, C. E. Beyer, Z. A. Hughes, X. Khawaja, J. E. Malberg and S. Rosenzweig-Lipson, “Innovative Approaches for the Development of Antidepressant Drugs: Current and Future Strategies,” NeuroRx, Vol. 2, No. 4, 2005, pp. 590-611. doi:10.1602/neurorx.2.4.590